Antipsychotic Drug Dosage and Therapeutic Response in Schizophrenia is Influenced by ABCB1 Genotypes: A Study from a South Indian Perspective

• Kinon BJ , ChenL, Ascher-SvanumH et al. Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia. Schizophr. Res. 102(1–3) , 230–240 (2008).
   PubMed Web of Science ®Google Scholar
• Ascher-Svanum H , NyhiusAW, FarisDE, KinonBJ, BakerRW, ShekarA. Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia. Schizophr. Bull.34(6) , 1163–1171 (2008).
   PubMed Web of Science ®Google Scholar
• Ayuso-Gutierrez JL , del Rio Vega JM. Factors influencing relapse in the long-term course of schizophrenia. Schizophr. Res.28(2–3) , 199–206 (1997).
   PubMed Web of Science ®Google Scholar
• Thieda P , BeardS, RichterA, KaneJ. An economic review of compliance with medication therapy in the treatment of schizophrenia. Psychiatr. Serv.54(4) , 508–516 (2003).
   PubMed Web of Science ®Google Scholar
• Kerwin RW , ArranzMJ. Psychopharmacogenetics. In: Psychiatric Genetics and Genomics. McGuffin P, Owen MJ, Gottesman II (Eds). Oxford University Press, UK, 397–414 (2002).
   Google Scholar
• Malhotra AK , MurphyGM Jr, Kennedy JL. Pharmacogenetics of psychotropic drug response. Am. J. Psychiatr.161(5) , 780–796 (2004).
   PubMed Web of Science ®Google Scholar
• Bebawy M , ChettyM. Differential pharmacological regulation of drug efflux and pharmacoresistant schizophrenia. Bioessays30(2) , 183–188 (2008).
   PubMed Web of Science ®Google Scholar
• Boulton DW , DeVaneCL, ListonHL, MarkowitzJS. In vitro P-glycoprotein affinity for atypical and conventional antipsychotics. Life Sci.71(2) , 163–169 (2002).
   PubMed Web of Science ®Google Scholar
• Maines LW , AntonettiDA, WolpertEB, SmithCD. Evaluation of the role of P-glycoprotein in the uptake of paroxetine, clozapine, phenytoin and carbamazapine by bovine retinal endothelial cells. Neuropharmacology49(5) , 610–617 (2005).
   PubMed Web of Science ®Google Scholar
• Moons T , de Roo M, Claes S, Dom G. Relationship between P-glycoprotein and second-generation antipsychotics. Pharmacogenomics12(8) , 1193–1211 (2011).
   PubMed Web of Science ®Google Scholar
• Zink M , EnglischS, Meyer-LindenbergA. Polypharmacy in schizophrenia. Curr. Opin. Psychiatr.23(2) , 103–111 (2010).
   PubMed Web of Science ®Google Scholar
• Sharom FJ . The P-glycoprotein efflux pump: how does it transport drugs? J. Membr. Biol.160(3) , 161–175 (1997).
   PubMed Web of Science ®Google Scholar
• Schinkel AH , WagenaarE, MolCA, van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Invest.97(11) , 2517–2524 (1996).
   PubMed Web of Science ®Google Scholar
• Eichelbaum M , FrommMF, SchwabM. Clinical aspects of the MDR1 (ABCB1) gene polymorphism. Ther. Drug Monit.26(2) , 180–185 (2004).
   PubMed Web of Science ®Google Scholar
• Mickley LA , LeeJS, WengZ et al. Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors. Blood 91(5) , 1749–1756 (1998).
   PubMed Web of Science ®Google Scholar
• Hoffmeyer S , BurkO, von Richter O et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl Acad. Sci. USA97(7) , 3473–3478 (2000).
   PubMed Web of Science ®Google Scholar
• Thomas R , NairSB, BanerjeeM. A crypto-Dravidian origin for the nontribal communities of south India based on human leukocyte antigen class I diversity. Tissue Antigens68(3) , 225–234 (2006).
   PubMedGoogle Scholar
• Vijayan NN , BhaskaranS, KoshyLV et al. Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a south Indian population. Behav. Brain Funct. 3 , 34 (2007).
   PubMed Web of Science ®Google Scholar
• Dingemans PM , LinszenDH, LeniorME, SmeetsRM. Component structure of the expanded Brief Psychiatric Rating Scale (BPRS-E). Psychopharmacol. (Berl.)122 , 263–267 (1995).
   PubMed Web of Science ®Google Scholar
• Woods SW . Chlorpromazine equivalent doses for the newer atypical antipsychotics. J. Clin. Psychiatry64(6) , 663–667 (2003).
   PubMed Web of Science ®Google Scholar
• Lachar D , BailleySE, RhoadesHM, VarnerRV. Use of BPRS-A percent change scores to identify significant clinical improvement: accuracy of treatment response classification in acute psychiatric inpatients. Psychiatr. Res.89(3) , 259–268 (1999).
   PubMed Web of Science ®Google Scholar
• Vahab SA , SenS, RavindranN et al. Analysis of genotype and haplotype effects of ABCB1 (MDR1) polymorphisms in the risk of medically refractory epiljpgy in an Indian population. Drug Metab. Pharmacokinet. 24(3) , 255–260 (2009).
   PubMed Web of Science ®Google Scholar
• Leucht S , DavisJM, EngelRR, KaneJM, WagenpfeilS. Defining ‘response‘ in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs. Neuropsychopharmacology32(9) , 1903–1910 (2007).
   PubMed Web of Science ®Google Scholar
• Dudbridge F . Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum. Hered.66 , 87–98 (2008).
   PubMed Web of Science ®Google Scholar
• Barrett JC , FryB, MallerJ, DalyMJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics21(2) , 263–265 (2005).
   PubMed Web of Science ®Google Scholar
• Gordon D , FinchSJ, NothnagelM, OttJ. Power and sample size calculations for case–control genetic association tests when errors present: application to single nucleotide polymorphisms. Hum. Hered.54 , 22–33 (2002).
   PubMed Web of Science ®Google Scholar
• Douglas JA , SkolAD, BoehnkeM. Probability of detection of genotyping errors and mutations as inheritance inconsistencies in nuclear-family data. Am. J. Hum. Genet.70 , 487–495 (2002).
   PubMed Web of Science ®Google Scholar
• Bozina N , KuzmanMR, MedvedV, JovanovicN, SerticJ, HotujacL. Associations between MDR1 gene polymorphisms and schizophrenia and therapeutic response to olanzapine in female schizophrenic patients. J. Psychiatr. Res.42(2) , 89–97 (2006).
   PubMed Web of Science ®Google Scholar
• Lin YC , EllingwoodVL, BishopJR, MillerDD. The relationship between P-glycoprotein polymorphisms and response to olanzapine treatment in schizophrenia. Ther. Drug Monit.28(5) , 668– 672 (2006).
   PubMed Web of Science ®Google Scholar
• Xing Q , GaoR, LiH et al. Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients. Pharmacogenomics 7(7) , 987–993 (2006).
   PubMed Web of Science ®Google Scholar
• Blanc O , BrousseG, MearyA, LeboyerM, LlorcaPM. Pharmacogenetic of response efficacy to antipsychotics in schizophrenia: pharmacodynamic aspects. Review and implications for clinical research. Fundam. Clin. Pharmacol.24(2) , 139–160 (2010).
   PubMed Web of Science ®Google Scholar
• Consoli G , LastellaM, CiapparelliA et al. ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients. Pharmacogenomics10(8) , 1267–1276 (2009).
   PubMed Web of Science ®Google Scholar
• Alenius M , WadeliusM, DahlML, HartvigP, LindströmL, Hammarlund-UdenaesM. Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting. J. Psychiatr. Res.42(11) , 884–893 (2008).
   PubMed Web of Science ®Google Scholar
• Sakaeda T , NakamuraT, OkumuraK. MDR1 genotype-related pharmacokinetics and pharmacodynamics. Biol. Pharm. Bull.25(11) , 1391–1400 (2002).
   PubMed Web of Science ®Google Scholar
• Kuzman MR , MedvedV, BozinaN, GrubišinJ, JovanovicN, SerticJ. Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia. Pharmacogenomics J.11(1) , 35–44 (2011).
   PubMed Web of Science ®Google Scholar
• Risselada AJ , MulderH, HeerdinkER, EgbertsTC. Pharmacogenetic testing to predict antipsychotic-induced weight gain: a systematic review. Pharmacogenomics12(8) , 1213–1227 (2011).
   PubMed Web of Science ®Google Scholar
• Jovanovic N , BozinaN, LovricM, MedvedV, JakovljevicM, PelesAM. The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naive patients with first-episode schizophrenia treated with risperidone. Eur. J. Clin. Pharmacol.66(11) , 1109–1117 (2010).
   PubMed Web of Science ®Google Scholar
• Kastelic M , KoprivsekJ, PlesnicarBK et al. MDR1 gene polymorphisms and response to acute risperidone treatment. Prog. Neuropsychopharmacol. Biol. Psychiatr.34(2) , 387–392 (2010).
   PubMed Web of Science ®Google Scholar
• Sim K , SuA, LeongJY et al. High dose antipsychotic use in schizophrenia: findings of the REAP (research on east Asia psychotropic prescriptions) study. Pharmacopsychiatry 37(4) , 175–179 (2004).
   PubMed Web of Science ®Google Scholar
• Bakare MO . Effective therapeutic dosage of antipsychotic medications in patients with psychotic symptoms: is there a racial difference? BMC Res. Notes12(1) , 25 (2008).
   Google Scholar
• Poolsup N , Li Wan Po A, Knight TL. Pharmacogenetics and psychopharmacotherapy. J. Clin. Pharm. Ther.25(3) , 197–220 (2000).
   PubMed Web of Science ®Google Scholar
• Lin KM , PolandRE, NuccioI et al. A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients. Am. J. Psychiatry 146(10) , 1307–1311 (1989).
   PubMed Web of Science ®Google Scholar
• Chang WH , JannMW, HwuHG et al. Ethnic comparison of haloperidol and reduced haloperidol plasma levels: Taiwan Chinese versus American non-Chinese. J. Formos. Med. Assoc. 90(6) , 572–578 (1991).
   PubMedGoogle Scholar
• Yoo HD , LeeSN, KangHA, ChoHY, LeeIK, LeeYB. Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of risperidone in healthy subjects with CYP2D6*10/*10. Br. J. Pharmacol.164(2b) , 433–443 (2011).
   PubMed Web of Science ®Google Scholar

▪ Websites

• UNPHASE 3.1. http://unphased.sourceforge.net
   Google Scholar
• 2-way contingency table analysis. http://statpages.org/ctab2x2.html
   Google Scholar
• Haploview 4.1. www.broadinstitute.org/scientific-community/science/programs/medical-and-population-genetics/haploview/haploview
   Google Scholar
• Power for association with error. http://linkage.rockefeller.edu/pawe
   Google Scholar
• PharmGKB: ABCB1. www.pharmgkb.org/gene/PA267
   Google Scholar